Posaconazole:

Camille Marchetti1, Emmanouil Glampedakis1, Jannik Stemler2,3,4

  • 1Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Mycoses
|October 15, 2025
PubMed
概括

在接受波萨可纳 (POS) 预防的患者中,突破性侵入性菌感染 (bIMI) 显著增加了死亡率. 原因尚不清楚,通常涉及POS敏感的病原体,没有明显的POS暴露不足.